AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet28-02-2024
28-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet28-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Analyst / Investor meet26-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Notice published in News Papers informing about dispatch of Postal Ballot Notices and evoting details.23-02-2024
AUROBINDO PHARMA LTD. - 524804 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Postal Ballot Notice seeking approval of the shareholders by way of Special Resolution through Postal Ballot, for appointment of Dr. (Mrs.) Deepali Pant Joshi as an Independent Director of the Company for a period of two years with effect from February 10, 2024.22-02-2024
Hold Aurobindo Pharma; target of Rs 1133: Sharekhan
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 1133 in its research report dated February 20, 2024.22-02-2024
Hot Stocks | Bet on Aurobindo Pharma, Tata Comm, Just Dial for healthy returns
The daily bullish candle and the hourly chart's pattern of higher-highs, higher-lows affirms the robust outlook, with the next rally potentially targeting the 22,300-22,350 range21-02-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding issuance of Letters of Confirmation in lie of share certificates lost16-02-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Submission of Earnings Call Transcript on Q3 FY2023-2416-02-2024